Norman Tse
Directeur/Bestuurslid bij Bio-Cancer Treatment International Ltd.
Profiel
Norman Tse has held positions as a Director at Bio-Cancer Treatment International Ltd.
since 2019 and as a Vice President at Nan Fung Life Sciences since 2017.
Actieve functies van Norman Tse
| Bedrijven | Functie | Begin |
|---|---|---|
Nan Fung Life Sciences
 Nan Fung Life Sciences Investment ManagersFinance Nan Fung Life Sciences (Nan Fung Life Sciences) is a venture capital subsidiary of Vervain Group (Holdings) Ltd founded in 1954 by Vincent Cheung. The firm is headquartered in Hong Kong. | Private Equity Analist | 01-10-2017 |
Bio-Cancer Treatment International Ltd.
 Bio-Cancer Treatment International Ltd. BiotechnologyHealth Technology Bio-Cancer Treatment International Ltd. is a Chinese company that focuses on researching and developing biological products and therapeutics for cancer and auto immune disorders. The company is based in Hong Kong, Hong Kong. The company was founded in 2000 by Jun Sing Lee and Paul Cheng, with Paul Cheng serving as the CEO since its inception. | Directeur/Bestuurslid | 01-06-2019 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Nan Fung Life Sciences
Nan Fung Life Sciences Investment ManagersFinance Nan Fung Life Sciences (Nan Fung Life Sciences) is a venture capital subsidiary of Vervain Group (Holdings) Ltd founded in 1954 by Vincent Cheung. The firm is headquartered in Hong Kong. | Finance |
Bio-Cancer Treatment International Ltd.
Bio-Cancer Treatment International Ltd. BiotechnologyHealth Technology Bio-Cancer Treatment International Ltd. is a Chinese company that focuses on researching and developing biological products and therapeutics for cancer and auto immune disorders. The company is based in Hong Kong, Hong Kong. The company was founded in 2000 by Jun Sing Lee and Paul Cheng, with Paul Cheng serving as the CEO since its inception. | Health Technology |
